Menlo Park, CA, June 01, 2023 –(PR.com)– Life Science Strategy Group (LSSG), the leading strategic consulting firm to the CRO industry, is pleased to announce the results of its new 2023 study, Biopharma Perceptions of Global CRO Thought Leadership, providing the first quantitative data, segmentation and insights into biopharmaceutical thought leadership and the degree to which leading, Top-10 global CROs are perceived as thought leaders across important trial design and conduct, functional expertise and technology and AI topics.

Based on input from 120 US and EU biopharma professionals, spanning medical and regulatory affairs, clinical operations, and C-suite, the report explores interest in and importance of elements of thought leadership, how perceived CRO thought leadership varies by geography, company size and stakeholder position level, best methods to establish and communicate thought leadership and which of the global CROs…